Conatus Pharmaceuticals (NASDAQ:CNAT)

CAPS Rating: 3 out of 5

Recs

1
Player Avatar sinvestor (46.24) Submitted: 1/14/2014 6:36:43 AM : Underperform Start Price: $12.16 CNAT Score: +51.42

Really???

Featured Broker Partners


Advertisement